PUBLISHER: Grand View Research | PRODUCT CODE: 1092574
PUBLISHER: Grand View Research | PRODUCT CODE: 1092574
The global spinal implants & devices market size is expected to reach USD 19.0 billion by 2030 and is expected to expand at a CAGR of 5.1% in the forecast period, from 2022 to 2030, according to a new report by Grand View Research, Inc. The growing number of vehicular accidents is leading to increasing new cases of spinal cord injuries (SCIs). Other causes of SCIs include falls, violence, acts of violence, sports and recreation injuries, and diseases. Vehicular or road accidents and falls account for the majority of SCI cases.
Fall-induced SCI is common among people aged 65 years and above. Acts of violence such as gunshot wounds or knife wounds account for around 12% of SCI cases. Sports activities such as diving in shallow water and impact sports lead to nearly 10% of SCIs. Cancer, osteoporosis, arthritis, and inflammation of the spinal cord also cause SCI.
Based on National Spinal Cord Injury Statistical Center data, around 296,000 U.S. population are currently living with SCI. SCI cases are rising; according to WHO, about 90 % of SCI cases are traumatic, however, the number of non-traumatic SCI cases is rising. Further, it stated that around 20-30% of SCI patients showed clinically significant signs of depression. This adversely affects patients' improvements in functioning and overall health. The consequences associated with SCI arise mainly due to inadequate access to medical care and rehabilitation services. Approximately 5-15 % of the population in middle- and low-income countries have access to the assisted devices needed to post spinal surgery.
Technological innovations in the field of spine surgery is also driving the market growth. Aprevo, by Carlsmed, is the first digital-to-device patient-specific interbody technology to treat adult spinal deformity (ASD). This system uses patient imaging data to create patient and surgeon-specific plans and develops personalized 3D printed spinal implants to achieve each plan. The titanium aprevo implants are personalized by shape, size, height, and coronal and lordotic angles. Since these implants provide more effective ASD treatment than a standard of care, so, in 2021, the U.S. FDA awarded aprevo Breakthrough Technology status.